PubMed Health⌕ Search

PubMed · 10367443

Thoracic geometry and its relation to electrical current distribution: consequences for electrode placement in electrical impedance cardiography.

Abstract

In thoracic impedance cardiography (TIC) measurements the neck electrodes are often positioned at the basis of the neck, close to the neck-thorax transition. Theoretically, this neck-thorax transition will cause inhomogeneities in the current density and potential distribution. This was simulated using a 3D finite element method, solely representing the geometrical neck-thorax transition. The specific conductivity was 7 10(-3) (omega cm)-1 and the injected current was 1 mA. As expected, the model generated inhomogeneities in the current distribution at the neck-thorax transition, which reached as far as 5 cm into the neck and 20 cm into the thorax. These results are supported by in vivo measurements performed in 10 young male subjects, in which the position of the neck electrodes was varied. A two-way ANOVA revealed that the stroke volume of the lowest neck position was significantly different from the other positions. Small shifts in the position of the neck electrode resulted in large changes in impedance and stroke volume (127 to 82 ml for the Kubicek equation). To standardise the electrode position, the authors strongly recommend placement of the neck electrodes at least 6 cm above the clavicula.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Raaijmakers, T J Faes, H G Goovaerts, J H Meijer, P M de Vries, R M Heethaar. 1998. Thoracic geometry and its relation to electrical current distribution: consequences for electrode placement in electrical impedance cardiography.. https://doi.org/10.1007/bf02524429

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Bioelectricity.

Explore the source record for details and available documents.

Cardiography, Impedance↗

Bioimpedance to prevent heart failure hospitalization.

Transthoracic and whole-body bioimpedance monitoring has been commercially available for years; however, attention to its use as a diagnostic and event-monitoring modality has not been routinely applied in patients with heart failure (HF). In 2005, intrathoracic bioimpedance monitoring via an implantable cardioverter defibrillator brought new awareness of bioimpedance technology. In addition, new knowledge about congestion in HF, including length of time a patient is congested before seeking emergency care, lack of sensitivity of common signs and symptoms used to monitor congestion and diagnose HF exacerbation, and poor clinical outcomes when hypervolemia is present, heightened the need for more aggressive assessment and management. Bioimpedance device monitoring provides data needed to make treatment decisions that promote euvolemia and optimal cardiac performance. This review summarizes three options for measurement of bioimpedance hemodynamic data, discusses its use in preventing HF hospitalization, and describes issues that need to be overcome before bioimpedance monitoring can be routinely used in HF management.

Cardiography, Impedance↗

Fetuses with congenital heart disease demonstrate signs of decreased cerebral impedance.

OBJECTIVE: The purpose of this study was to determine whether fetuses with a congenital heart defect demonstrate changes in cerebrovascular impedance. STUDY DESIGN: Fetal echocardiograms from January 2001 to May 2005 were reviewed. Cases had sonographically diagnosed congenital heart defects; control subjects were gestational age-matched fetuses with normal echocardiograms. The pulsatility index in the middle cerebral artery was used to measure impedance to cerebral blood flow. Abnormal middle cerebral artery pulsatility index was defined as less than the 5th percentile. Cases were subgrouped into mixing versus nonmixing lesions. RESULTS: Of 142 total fetuses, there were significantly more abnormal middle cerebral artery pulsatility indices in the cases (5/71) than in the control subjects (0/71; P = .023); all abnormal middle cerebral artery pulsatility indices occurred in the fetuses with admixing cardiac lesions. CONCLUSION: Fetuses with congenital heart defect are significantly more likely to have decreased cerebrovascular impedance. This may represent a marker of cerebral hypoxemia that is due to intracardiac mixing of oxygenated and deoxygenated blood. Theoretically, this hypoxemia may contribute to the cause of abnormal neurologic development in these infants.

Cardiography, Impedance↗